Rebalix
Amundi · sheet of 10 September 2026
Amundi · sheet of 10 September 2026ETF sheet · official issuer and register data
Amundi MSCI USA Daily (2x) Leveraged UCITS ETF Acc
CL2 · FR0010755611 · class Acc · EUR · domicile France
Equity · United Statesleveraged 2xSFDR art. 6
Index tracked: MSCI USA Leveraged 2X Index
- TER
- 0.50%+ trans. 0.00%
- Fund size
- 1.1 bn EUR
- Tracking difference
- −0.79%3-year avg
- 🇮🇹 tax rate
- —white list not published
- Replication
- Synthetic (swap)
- Income
- Mixed (acc. and/or dist.)
Launch 16 Jun 2009 · costs from the KID as of 2 Sept 2026 · 64 securities held · 10 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
By subscribing to Amundi MSCI USA Daily (2x) Leveraged UCITS ETF (the "Fund"), you are investing in a passive management UCITS whose objective is to replicate, as accurately as possible, the performance of the MSCI USA Leveraged 2x Daily strategy index (the "Strategy Index"), regardless of its performance, positive or negative. The maximum tracking error objective between the growth of the net asset value of the Fund and that of the Index is indicated in the Fund's prospectus. The Strategy Index, net dividends reinvested (dividends net of tax paid by the…
Performance since series start (in euro) — base 100
10 Jul 2017 → 8 Sept 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +38.1% |
| 3 years | +121.8% |
| 5 years | +136.9% |
| 10 years | series too young |
| Since series start | +630.2% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 25.14% | 31.57% | 34.87% |
| Max drawdown | −15.54% | −41.47% | −41.47% |
| Sharpe | 1.29 | 0.88 | 0.59 |
| Sortino | 1.86 | 1.26 | 0.83 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · CL2 · FR00107556111
RebalixCL2 · FR0010755611 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · declared by the issuer
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | −0.19% | +0.42% | −0.61% |
| 2024 | +65.62% | +66.73% | −1.11% |
| 2023 | +41.19% | +41.83% | −0.64% |
| 2022 | −31.43% | −31.11% | −0.32% |
| 2021 | +81.38% | +82.21% | −0.84% |
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 1 Sept 2026 · 64 securities · top-10 weight = 46.7%
| Top holdings | Weight |
|---|---|
| 5.8% | |
| 5.5% | |
| 5.1% | |
| 4.8% | |
| 4.7% | |
| 4.7% | |
| 4.3% | |
| 4.2% | |
| 3.8% | |
| 3.7% |
Listing venues
ESMA register (FIRDS) and official exchange lists
CL2 · Borsa Italiana (ETFplus), Euronext Paris
— · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
CL2GR · Xetra (Deutsche Börse)
+ 24 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/FR0010755611
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/FR0010755611
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · CL2 · FR00107556112